ctrl K

/

Search

Popular

KO Coca Cola Company

Stock
TSLA Tesla Inc

Stock
AMD Advanced Micro Devices

Stock
SPY SPDR S&P 500 ETF Trust

ETF
NVDA Nvidia

Stock

Stock Analysis Pro

JAGX 0.61

AI Score

Unlock

Jaguar Health Inc. (JAGX)

AI Score

Unlock

0.61

-0.01 (-1.10%)

At close: Mar 03, 2025, 12:12 PM

Insider Trading

Congress Trading

Congress Trading

No data available

JAGX News

4 days ago - Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value - accessnewswire.com
12 days ago - Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure (SBS-IF) - accessnewswire.com
13 days ago - Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300 - accessnewswire.com
18 days ago - Jaguar Health Presenting February 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts - accessnewswire.com
25 days ago - Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference - accessnewswire.com
28 days ago - Jaguar Health Announces First Patient Dosed in Short Bowel Syndrome with Intestinal Failure in Investigator-Initiated Trial of Crofelemer; Proof-of-Concept Data Potentially Available H1 2025 - accessnewswire.com
33 days ago - Jaguar Health Supports Evaluation of FDA-Approved Crofelemer to Address GI Side Effects of GLP-1 and Other Weight Loss Therapies: Files Patent Application with USPTO - accessnewswire.com
40 days ago - Jaguar Health Announces First Patient Dosed in Investigator-Initiated Trial (IIT) Evaluating Crofelemer for the Rare Disease Indication of Microvillus Inclusion Disease (MVID), with Proof-of-Concept (POC) Data Potentially Available H1 2025 - accessnewswire.com

Create Price Alert on JAGX

Symbol JAGX, Regular trading hours

Condition

Crossing

Value

Quick Summary:

Your price alert will notify you when the stock price is above 0.61.

Cancel

✕

Add to Watchlist

Sections

Stocks
ETFs
Blog
Learning Center

Services

Pro Pricing
Pro Newsletter
Support Us ❤

Website

Login
Sitemap
Advertise
Data Disclaimer
Affiliate Program

Company

About Us
Contact Us
Terms of Use
Privacy Policy
Imprint

Stocknear is 100% Open Source⚡ © 2025 Stocknear. All Rights Reserved.